Arctic Bioscience AS (DE:9TD) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Arctic Bioscience AS is set to announce its first half-year financial results for 2024 on August 29th, followed by a webcast presentation and Q&A session to provide an operational update and engage with the audience. The company specializes in developing pharmaceuticals and nutraceuticals, including HRO350, a novel drug candidate aimed at treating mild-to-moderate psoriasis, and markets the ROMEGA® brand globally.
For further insights into DE:9TD stock, check out TipRanks’ Stock Analysis page.
